ABEONA THERAPEUTICS INC.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2023 (Q4)
Revenue
$5M
Gross Profit
$4M
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) |
|---|---|
| Revenue | $5M |
| COGS | $1M |
| Gross Profit | $4M |
| R&D | $7M |
| SG&A | $19M |
| D&A | $863K |
| Other OpEx | $0 |
| Operating Income | $0 |
| Interest Exp. | $0 |
| Other Non-Op | $0 |
| Pretax Income | $0 |
| Tax | $0 |
| Net Income | $0 |
QuarterCharts · SEC EDGAR data · ABEO · Comparing FY2025 (Q4) vs FY2023 (Q4)